Aligos Therapeutics (ALGS) Other Accumulated Expenses (2019 - 2026)
Aligos Therapeutics' Other Accumulated Expenses came in at $4.13 million for Q3 2026, down 14.4% from $4.83 million a year earlier and down 41.2% from the prior quarter.
Aligos Therapeutics (ALGS) Other Accumulated Expenses (2019 - 2026) Analysis & Trends
At the end of FY2025, Aligos Therapeutics' Other Accumulated Expenses was $3.25 million, down 39.6% from FY2024.
- Other Accumulated Expenses carries a five-year compound annual growth rate of 81.1% (FY2020 to FY2025).
- Going back by year, Other Accumulated Expenses was $5.38 million in FY2024 (-18.9%), $6.63 million in FY2023 (+350.3%), $1.47 million in FY2022 (+19.3%) and $1.24 million in FY2021 (+639.5%).
- The five-year range for quarterly Other Accumulated Expenses is $856,000 (Q2 2022) to $7.03 million (Q2 2026).
- Year-over-year, Other Accumulated Expenses increased in five of the last eight quarters, with growth averaging 21.8%.
- The fastest year-over-year change in Other Accumulated Expenses over five years came in Q4 2021 (growth of 639.5%), and the weakest in Q4 2025 (a decline of 39.6%).
- Business Quant data shows ALGS's Other Accumulated Expenses at $7.03 million (Q2 2026), $4.26 million (Q1 2026) and $3.25 million (Q4 2025) in the three quarters before Q3 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,359.75 Bn | 1,333.37 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 688.76 Bn | 608.62 Bn | 17.30 Bn |
| 3 | AbbVie | 521.69 Bn | 489.75 Bn | 13.12 Bn |
| 4 | Merck | 364.31 Bn | 327.31 Bn | 13.19 Bn |
| 5 | Novartis Ag | 306.35 Bn | 279.93 Bn | - |
| 6 | Astrazeneca | 285.96 Bn | 259.56 Bn | 13.26 Bn |
| 7 | Amgen | 251.88 Bn | 203.53 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 208.59 Bn | 183.61 Bn | 6.73 Bn |
| 9 | Pfizer | 164.73 Bn | 112.38 Bn | 12.56 Bn |
| 10 | Aligos Therapeutics | 21.97 Mn | -314.86 Mn | - |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 4.13 Mn |
| Jun 30, 2026 | 7.03 Mn |
| Mar 31, 2026 | 4.26 Mn |
| Dec 31, 2025 | 3.25 Mn |
| Sep 30, 2025 | 4.83 Mn |
| Jun 30, 2025 | 3.82 Mn |
| Mar 31, 2025 | 3.85 Mn |
| Dec 31, 2024 | 5.38 Mn |
| Sep 30, 2024 | 2.75 Mn |
| Jun 30, 2024 | 2.71 Mn |
| Mar 31, 2024 | 2.84 Mn |
| Dec 31, 2023 | 6.63 Mn |
| Sep 30, 2023 | 1.26 Mn |
| Jun 30, 2023 | 1.44 Mn |
| Mar 31, 2023 | 2.27 Mn |
| Dec 31, 2022 | 1.47 Mn |
| Sep 30, 2022 | 912,000.00 |
| Jun 30, 2022 | 856,000.00 |
| Mar 31, 2022 | 1.14 Mn |
| Dec 31, 2021 | 1.24 Mn |
Aligos Therapeutics Other Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=ALGS&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-accumulated-expenses", "ticker": "ALGS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=ALGS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();